medical care promptly to prevent HF exacerbations by calling their physician when signs and symptoms of HF began to increase.
The primary aim of the study was to compare the impact of 2 different intensity levels of HF patient education focused on volume-overload prevention and self-care enhancement with control (usual care) and with each other on the composite end point of cardiac death or HF hospitalizations. Patients were followed up for 2 years. A secondary aim was to test the role of potential moderators (type of HF [ie, HFREF or HFPEF], age, and sex) on clinical outcomes.
Methods Trial Design and Participants
The randomized, clinical trial (Rural Education to Improve Outcomes in Heart Failure [REMOTE-HF]) was approved by the Institutional Review Board of each participating institution. Patients were recruited from 12 clinics or hospitals in California, Kentucky, and Nevada. To be eligible for the study, patients had to be ≥18 years of age and to live in a rural area defined as a town of <2500 people, a metropolitan center of <50 000 people, or open country. 16 They also must have been hospitalized for HF within the past 6 months, able to read and write English, and living independently (ie, not living in an institutional setting and having primary decision-making ability over health issues). Patients were excluded if they had a complicating serious comorbidity (eg, a psychiatric illness, untreated malignancy, or renal failure requiring dialysis), were currently participating in an HF disease management program, or had a neurological disorder that impaired cognition. Cognitive status was determined by use of the Mini-Cog test 17 and a clockdrawing test. 18 The clock-drawing component of the test provided a quick assessment of cognitive function, memory, language comprehension, visual-motor skills, and executive function and thus screened out patients with dementia or mild cognitive impairment. 18 Patients with a word recall score of 0 (range, 1-3) or a word recall of ≤2 with an abnormal clock drawing were excluded. 17, 18 Reading difficulty secondary to eyesight problems was not a cause for exclusion, and large-print questionnaires and diaries and digital scales with large numbers were available to all enrolled patients.
Procedures
After written informed consent was obtained from each patient, sociodemographic data (ie, age, sex, race/ethnicity, education, annual household income, marital status, and number of people living in the household) were collected with structured questionnaires. Clinical data were abstracted from hospital medical records by trained research personnel using a standardized form, and medication reconciliation was performed at that time. Echocardiograms were obtained if not conducted in the previous 6 months. Assessment of New York Heart Association class was determined by the patient's physician or research nurse before randomization.
Patients were randomized to 1 of the 3 groups at each site with the use of random selection techniques available in SPSS 18.0 with 1:1:1 fixed allocation randomization using blocks of 5 patients. Randomization assignment was placed in sealed envelopes in sequential order at each site. The study nurse opened the envelope to determine group assignment after the patient completed baseline testing. Patients and their physicians were blinded to group assignment. Research assistants and investigators also remained masked to study arm assignment. Contamination of groups was minimized because none of the medical practices had HF clinics or patient group sessions, patients lived in geographically diverse areas, and the intervention in both experimental groups was delivered in the patient's home or a private room in one of the participating clinics. Data were collected at baseline and at 3, 12, and 24 months and were entered directly onto TeleForms and faxed to the Clinical Trials Coordinating Center.
Patients in all 3 groups were provided with educational brochures about HF from the American Heart Association, as well as healthcare logs to document telephone calls to physicians, medical appointments (both scheduled and unscheduled), emergency department admissions, and hospitalizations. Physicians were not told of the group assignment of their patients. Patients in the 2 intervention groups were given daily weight and HF symptom diaries to be completed and weight scales. Both the healthcare logs and diaries were returned monthly in stamped, self-addressed envelopes to the appropriate project director. All patients were compensated $25.00 per visit. Follow-up data were collected in person by a research nurse in either the patient's home or the physician's office or clinic.
Patients in the 2 experimental arms met with a nurse for an educational session lasting ≈50 minutes. The education was enhanced by a structured flip chart to promote intervention fidelity across sites, but every effort was made to make the session as interactive as possible using the strategies of "teach-back" in which patients are asked to repeat what they have been taught. 19 The intervention session was based on current clinical guidelines 14, 15 and included information about HF; a discussion of common barriers to seeking care; a review of the patient's dry weight and signs and symptoms of fluid overload; tailored messages on the importance of medication adherence, diet, and self-monitoring of symptoms; and supportive coaching to identify barriers to seeking care and to develop action plans. The rationale for the emphasis on weight monitoring and, if appropriate, diuretic self-adjustment was based on research demonstrating that adherence to this area of self-care is associated with fewer HF-related hospitalizations. 20 Nurses in the intervention session had a list of the patients' medications, and they tailored the medication teaching accordingly. On the basis of our pilot study in which patients kept a daily log but did not use the data to alert their physician when they experienced weight gain or increased HF symptoms, 21 we provided all patients in the 2 experimental arms with a script to use when calling their physicians, and we reviewed the importance of contacting a physician when they experienced weight gain or increased HF symptoms. A similar script tested in a randomized, controlled trial in cancer patients was found to improve clinical outcomes related to pain management. 22 Patients in the Fluid Watchers LITE group received 2 phone calls at 2-week intervals to reinforce the information in the educational session. Patients in the Fluid Watchers PLUS group received an audiotape of the education session for future review and biweekly follow-up phone calls by the research nurse until content competency was demonstrated. The expected level of knowledge competency was a focus of staff training and reinforced through role playing. The nurses were encouraged to use the teach-back technique 19 in the educational sessions to determine patients' understanding of the concepts taught. The mean number of follow-up telephone calls was 5.3±3.6 (range, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Family members were invited to participate in the educational session and did so approximately one third of the time (35% of the time in the LITE group and 37% of the time in the PLUS group).
Comorbidities were assessed with the Charlson Comorbidity Index. 23 Knowledge about HF was assessed with a 20-item HF Knowledge Scale. 24 Health literacy was measured with the Short Test of Functional Health Literacy in Adults, which is a 36-item, 7-minute timed test of reading comprehension. 25 The instrument measures the ability to read and understand actual health-related passages. Depending on the number of correct answers, patients are categorized as having inadequate (0-16 correct answers), marginal (17-22 correct answers), and adequate (23-36 correct answers) health literacy. The Short Test of Functional Health Literacy in Adults has good internal consistency (Cronbach α=0.98) and demonstrated concurrent validity compared with the long version (r=0.91).
25
The 9-item European HF Self-Care Behavior Scale 26 was used to measure HF-related self-care. Sample items include "I weigh myself every day" and "If my shortness of breath increases, I contact my doctor or nurse." Responses on each item are measured on a 5-point Likert scale ranging from 1 (completely agree) to 5 (do not agree at all). The total score can range from 9 to 45, with lower scores indicating better self-care. The scale has excellent data supporting its validity and reliability, 26 and in our sample, internal reliability was acceptable with a Cronbach α of 0.72.
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Hospitalizations were determined at each data collection point by questioning patients and their physicians. Cause of hospitalizations was determined by medical record review. Mortality was determined by medical record review using a blinded adjudication process to determine cause of death and interview of the patient's family member or physician for out-of-hospital deaths. All deaths were confirmed with Social Security Death Index, and copies of death certificates were obtained.
No changes in the criteria for enrollment or study procedures were made once the trial was initiated. We collected participant contact information, including 2 alternative contacts, at enrollment to minimize loss to follow-up.
Sample Size
Using data from previous trials, 4, 5, 27, 28 we estimated the proportion of patients who would experience either cardiac death or HF rehospitalization over the 2 years of follow-up in the control group at 72%. An absolute 15% decrease in the composite end point in the LITE group (57%) and an absolute 30% decrease in the PLUS group (42%) were considered both realistic and clinically relevant. With a power of 80%, an α level of 0.05 for the overall χ 2 test, and more specifically, an α of 0.017 (0.05/3) for the 3 subsequent pairwise contrasts, 212 patients were required in each arm.
Statistical Analysis
Data were analyzed with SPSS for Windows (version 18.0, SPSS, Inc, Chicago, IL). Comparability of the groups on baseline measures was examined with χ 2 or 1-way ANOVA, depending on the level of measurement. All analyses followed an intent-to-treat strategy, that is, the analyses included all patients in the groups to which they were randomly assigned, regardless of their level of adherence to the intervention or subsequent withdrawal from the study. All significance levels used and P values presented are 2 sided.
Differences in self-care scores among the groups over the study period were tested with a linear mixed-models analysis. The analysis examined the main effects of group and time and the group-bytime interaction. The within-patient covariance structure was set at unstructured. Pairwise comparisons between groups at each time point were tested by use of the Bonferroni correction for multiple comparisons at a total α of 0.05; that is, to be significant, the P value of a pairwise comparison would need to be <0.017 (0.05/3). The difference in the proportions of HF hospital admissions or cardiac death was tested with χ 2 analysis with significance set at P<0.05 and potential pairwise differences between groups set at P<0.017. Differences among groups in time to first occurrence of the combined end point of HF hospital admission or cardiac death and individual end points of HF hospitalization and cardiac death were analyzed with Cox proportional hazards estimates of the survival curves. Sex, age, and ejection fraction (≤40% or >40%) were used as covariates. The Wald statistic was used to compare survival curves.
Results
We screened patients from September 2006 through December 2010, with the last follow-up completed in January 2012. Of the 636 patients eligible for enrollment, 12 did not meet eligibility criteria for cognitive function, and 10 chose not to participate ( Figure 1 ). Of the 614 HF patients who were enrolled, 12 (2%) were lost to follow-up before the first follow-up at 3 months, and we could not obtain data about their clinical outcomes. The remainder of those who withdrew (n=97, 15.8%) gave us written permission to follow up their outcomes. The rate of withdrawal from the treatment groups was lowest in the control group (13.6%) and highest in the LITE group (19.2%), but these percentages were not significantly different across the 3 groups (P=0.096). Patients who withdrew from the study were not significantly different from patients who remained in the study on any of the demographic or clinical characteristics measured at baseline, including health literacy scores with significance set at <0.05.
Of the 602 patients available for analysis of clinical outcomes at 2 years (98% of the enrolled sample), they were on average 66±13.0 years of age; the majority were male (58.7%) and married (56.6%). Sixty-five percent had combined household incomes of less than $40 000 per year. Fifty-one percent had HFREF. The majority of patients (85.4%) were classified as being in New York Heart Association class II or III. The mean score on the Short Test of Functional Health Literacy in Adults was 70.9±24.6 (range, 2.8-100), with 18.8% scoring as inadequate, 15.7% as marginal, and 61.3% as adequate. Demographic and clinical characteristics of patients by total sample and group assignment are summarized in Table 1 . There were no significant differences among the 3 groups on any demographic or clinical characteristic except history of hypertension.
Given that the intervention focused on enhancing patients' self-care of their HF regimen, we examined self-care scores over time. The linear mixed-models analysis found a nonsignificant main effect of group (P=0.062), a significant main effect of time (P<0.001), and a significant group-by-time interaction (P=0.003). Pairwise comparisons among the groups at each time were examined. The means and standard errors of each group at each time are presented in Table 2 . At baseline, there were no significant differences among the groups. At 3 and 12 months, there were some significant differences among the groups (P<0.05). At 3 and 12 months, both the LITE and PLUS groups had significantly lower (better) self-care scores than the control group (P<0.05), with no difference between the 2 intervention groups. At 24 months, the improvement in the 2 intervention groups in self-care behavior was sustained but was no longer significantly different from the control group (control versus PLUS, P=0.095; control versus LITE, P=0.116).
Over 2 years of follow-up, 35% of patients (n=211) experienced either cardiac death or hospitalization for HF (Table 3) . Groups did not differ significantly in the proportion who had the combined clinical outcome of cardiac death or hospitalization for HF (P=0.058). There was a trend favoring the Fluid Watchers LITE group compared with the control (P=0.048) and PLUS (P=0.033) groups, but neither comparison met the criteria of P<0.0167 with the use of the Bonferroni correction for multiple comparisons. There were no differences among the groups in time to HF hospitalization or cardiac death (χ 2 =3.577; P=0.167; Figure 2 ). When age, sex, and type of HF, characteristics that have been identified by previous investigators as potentially affecting this combined clinical outcome, 5, 28 were also included in the Cox survival analysis, there were still no significant differences among the groups (P=0.154). We also tested the effect of site on the primary clinical end point and demonstrated no significant interaction between treatment group and site (P=0.169).
During 2 years of follow-up, 75 patients (12.5%) died of a cardiac cause. Cardiac mortality was significantly different among the groups (P=0.008). The proportion of patients who experienced a cardiac death was significantly less in the LITE group (7.5%) compared with the control group (17.7%; P=0.003). Differences in cardiac deaths between the LITE and PLUS groups (P=0.172) and the control and PLUS groups (P=0.123) were not significant. Cox survival analysis of time to cardiac death also showed a significant difference among groups (χ 2 =8.741; P=0.013). Survival was significantly better for the LITE group than for the control group (P=0.005; Figure 3 ). Cardiac mortality was not significantly different between the PLUS and control or the PLUS and LITE groups. Including age, sex, and type of HF did not alter the test of the group effects. Eight percent of patients (n=50) died of noncardiac causes.
We also examined the number of scheduled and unscheduled office visits made by patients to their physicians over the study period. Patients in the LITE group made the fewest visits (11.5%) compared with patients in the control (12.9%) and PLUS (23.8%) groups (P=0.001; Table 3 ). Finally, we examined the potential role of family presence in the intervention sessions and identified no significant difference between the 2 intervention groups, with 35% of the LITE group and 37% of the PLUS group sessions attended by family members (P=0.68).
Discussion
Patient education designed to achieve optimal self-care in HF such as monitoring daily weight and maintaining adherence to medication and dietary regimens is recommended in all HF guidelines.
14,15 Self-care is also a fundamental component of comprehensive HF disease management programs, which in turn are documented to improve all-cause hospitalization and survival. 4, 5, [27] [28] [29] However, such programs are usually not available to patients living in rural areas who are geographically distant from specialty care. Moreover, urban-rural differences in mortality, morbidity, access to care, and cost of care have been documented in a variety of clinical conditions, 30 including HF, 31 with rural populations disadvantaged on every dimension. These differences may be compounded by the demographic differences between rural and urban populations, which include lower incomes and educational levels, less medical insurance and access to health care, and higher healthcare risk factors. [6] [7] [8] [9] Thus, patients living with HF in rural areas of the United States pose specific challenges for the healthcare system, given the demands related to having a complex chronic condition To date, the special population of rural HF patients has not been the subject of an educational intervention study designed to enhance self-care. We enrolled 614 HF patients living in rural areas of Appalachia, central California, and Nevada and randomized them to 1 of 3 treatment groups to determine whether a face-to-face, 1-time educational intervention designed to improve knowledge and to enhance self-care would reduce HF-related hospitalization or cardiac death. We designed the trial to see whether the intensity of the intervention, as reflected by additional telephone reinforcement sessions and provision of an audiotape of the educational session, would make a significant difference in the hypothesized clinical outcomes over the 2 years of follow-up.
The results demonstrated a lack of significant difference across the 3 groups in the combined end point of HF hospitalization or cardiac death, although there was a trend favoring the LITE treatment group. One potential explanation for the unexpected finding of no difference in the composite end point between groups might be that approximately half of the patients in the study had HFPEF by echocardiogram. The evidence related to optimal self-care in patients with HFPEF is limited, and self-care measures are not proven effective in this group of patients. However, a Cox analysis using type of HF as a covariate demonstrated no significant difference in the composite end point by group, suggesting that type of HF did not play a significant role in the findings. In addition, the proportion of patients with HFPEF compared with patients with HFREF was not significantly different among groups.
Another potential explanation of our finding of a lack of difference among groups in the combined outcome of cardiac mortality and rehospitalization for HF may be the lack of integration of the patients' physicians in the trial. Keeping the physicians blinded to patient assignment reduced a potential bias in the trial, but the lack of collaboration between the nurses who provided the educational intervention and the physicians who cared for the patients might explain the smaller beneficial effects that accrued. This observation was made by both Jaarsma et al 32 about the Community Outreach and Cardiovascular Health (COACH) trial and Angermann et al 33 about the Interdisciplinary Network for Heart Failure (INH) trial. Both studies tested a nurse-coordinated intervention and had similar findings to ours. It may be that the strong benefit noted in HF interdisciplinary disease management programs 4, 5 is a result of the collaboration that occurs between physicians and nurses and the uniformity of their approach to patients and their caregivers.
In an examination of mortality from cardiac causes specifically, patients in the Fluid Watchers LITE group had significantly fewer cardiac deaths (7.5% versus 17.7%) over the 2 years of follow-up compared with either the control or the PLUS group. Because the groups were equivalent in all demographic and clinical variables except hypertension history and because HF hospitalization rates were not significantly different across groups in the 2 years of follow-up, we examined the data for other potential explanations of differences in cardiac deaths. Patients in the PLUS group had almost twice as many physician visits as patients in the LITE group. On reflection, this higher number of visits is not surprising in that nurses focused on reviewing the daily logs with the patients and encouraged them to call their physicians if they experienced an increase in weight or HF symptoms, particularly in the extra telephone reinforcement sessions of the PLUS group. Although not significant, hospital admissions for HF were highest in the PLUS group compared with both the control and LITE groups, suggesting that physicians may have responded to patients' concerns or changes in weight or symptoms by recommending hospitalization.
A recent comparative effectiveness research study 34 evaluated a similar HF self-care training intervention with both intervention groups receiving a single face-to-face training session and then patients being randomized to either the single-session or a multisession group receiving 5 to 8 phone calls over 4 weeks. The primary hypothesis was a decrease in allcause death and hospitalization in the multisession group, and data were collected over 12 months. The investigators found no differences between the 2 groups until an analysis was conducted by literacy levels. Among those with higher literacy, the multisession intervention yielded a higher incidence of allcause hospitalization and death. The investigators suggested that for these patients "the additional phone calls may have led to closer attention to symptoms and subsequently more admissions." 34 Although the setting was urban, these findings partially confirm our experience with worse outcomes in the intervention group when patients received multiple reinforcement calls. Baseline testing revealed no differences in literacy levels in our study, and the majority of patients demonstrated adequate literacy, but the findings of DeWalt and colleagues 34 suggest that literacy is an important characteristic to be assessed in any test of an education intervention.
Ultimately, the primary hypothesis of our trial was based on a composite end point, and the hypothesis was rejected. Composite end points have been used in many HF trials to increase statistical power. 35, 36 However, composite end points increase statistical power only if the intervention has a similar effect on multiple aspects of the composite. The inclusion of factors in the composite end point that are not affected by the intervention or even are affected negatively dilutes the observed treatment effect and decreases the overall statistical power. Although hospitalizations for HF have been a target for intervention over the past several decades because of the high cost incurred by the healthcare system, particularly for Medicare patients, investigators may want to reconsider the wisdom of using this target as an outcome variable. Hospitalizations as an end point are sensitive to the judgment of the clinician and the unique situation of each HF patient and family and thus may not be an accurate assessment of the effect of a particular intervention. In addition, except for the first 30 days after hospitalization for HF in Medicare patients, the current system incorporates powerful forces that encourage hospitalization of HF patients for both financial and legal reasons, which are not necessarily influenced by an intervention focused on increasing HF patient's self-care. The heterogeneity in the results of various trials testing educational interventions for the HF population may be partially explained by methodological variances in length of followup, category of outcomes measured, and type of intervention tested (eg, disease management, 1-time education session, telephonic follow-up, remote monitoring), as well as the demographic and clinical variances in patients. Other investigators who have documented reductions in mortality with increases in healthcare resources, particularly hospitalizations, that were similar to ours have noted that heterogeneity in outcomes makes it difficult to recommend a single educational model to promote self-care and improve clinical outcomes. 37, 38 Cardiac mortality is clinically relevant, simple, and relatively inexpensive to measure. It is also unambiguous. From the patient's perspective, cardiac mortality may not be as relevant as all-cause death, and from the investigator's standpoint, it implies the added burden of expanding the sample size of a study with a concomitant demand for increased funding. 38 However, an intervention such as the one in this trial that is focused specifically on preventing HF exacerbations is best evaluated using the specific outcome most germane to the intervention, which is cardiac death.
Limitations
First, the rural population targeted for this trial was unique and thus the ability to generalize our results to other HF populations, particularly those in urban settings or in countries other than the United States, is limited. Second, any face-to-face encounter is difficult to standardize. Intervention fidelity was enhanced by training sessions with all nurse educators and the use of flip charts and checklists in the intervention session. Moreover, the fact that the same nurse provided education to patients in both intervention groups at the various sites suggests that the approach and content were similar across the 2 groups and that any differences in outcome are based on the reinforcement strategies. Nonetheless, the intervention is complex, and there may have been differences between the 2 groups that were not appreciated by the investigators. Third, follow-up extended over 2 years, and it can be assumed that physicians changed medication regimens or other aspects of treatment over that time. Medications were recorded only at baseline. Although there were no differences between groups in the proportion of patients on specific medications on enrollment, we cannot be sure that the difference in cardiac mortality between the LITE and control groups was not related to changes in patients' medical regimen. Nonetheless, given that physicians were blinded to patient assignment, it would seem that such changes should be random and therefore not linked to the positive outcome of 1 group. Finally, it is recognized that efforts to distinguish cardiovascular deaths from other lethal events are not always successful. 39 Although we used the usual blinded adjudication process and death certificates to determine cause of death, some mortality events may have been misclassified.
Conclusions
A face-to-face education and counseling intervention delivered by a nurse and focused on increasing knowledge about HF and self-care in patients with HF living in rural areas did not significantly decrease the combined end point of cardiac death or rehospitalization for HF, although self-care behaviors increased in both intervention groups and cardiac mortality was significantly decreased. Increasing the number of contacts between the patient and nurse did not significantly improve the outcome.
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